Compounds for inhibiting 1-deoxy-D-xylulose-5-phosphate reductoisomerase

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9593136
APP PUB NO 20140378418A1
SERIAL NO

14130384

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

In particular, the compound is effective to inhibit Dxr in Mycobacterium tuberculosis (Mtb). The present invention relates to compounds having general formula (I) or (II)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICESOFFICE OF TECHNOLOGY TRANSFER NATIONAL INSTITUTES OF HEALTH 6701 ROCKLEDGE DRIVE SUITE 700 MSC 7788 BETHESDA MD 20892-7788

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Boshoff, Helena I Potomac, US 2 3
Dowd, Cynthia S Washington, US 4 4
Jackson, Emily R Springfield, US 2 75
Kehn-Hall, Kylene Fredericksburg, US 4 18
Lee, Richard E Cordova, US 30 241
Lee, Robin Cordova, US 46 700
San, Jose Geraldine Mios, FR 1 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 14, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00